Safety, immunogenicity, and cross-species protection of a plasmid DNA encoding Plasmodium falciparum SERA5 polypeptide, microbial epitopes and chemokine genes in mice and olive baboons.

Incorporation of biomolecular epitopes to malarial antigens should be explored in the development of strain-transcending malarial vaccines. The present study sought to determine safety, immunogenicity and cross-species efficacy ofPlasmodium falciparum serine repeat antigen 5 polypeptide co-expressed with epitopes of Bacille-Calmette Guerin (BCG), tetanus toxoid (TT) and a chemokine gene. Olive baboons and BALB/c mice were randomly assigned into vaccine and control groups.

Methylene blue inhibits lumefantrine-resistant Plasmodium berghei.

Introduction: Chemotherapy still is the most effective way to control malaria, a major public health problem in sub-Saharan Africa. The large-scale use of the combination therapy artemether-lumefantrine for malaria treatment in Africa predisposes lumefantrine to emergence of resistance. There is need to identify drugs that can be used as substitutes to lumefantrine for use in combination therapy.

Parasite accumulation in placenta of non-immune baboons during Plasmodium knowlesi infection.

Background: Placental malaria (PM) causes adverse pregnancy outcomes in the mother and her foetus. It is difficult to study PM directly in humans due to ethical challenges. This study set out to bridge this gap by determining the outcome of PM in non-immune baboons in order to develop a non-human primate model for the disease.

Evaluation of immune associated cells in lesions of L. major infected vervet monkeys (Cercopithecus aethiops).

Vervet monkeys were used to characterize immune associated cell types recruited into lesion sites as a result of experimental primary and secondary infections with Leishmania major. A heavy cellular infiltration consisting primarily of CD8+ (cytotoxic/suppressor) T cells were observed in the lesions. A small number of B lymphocytes and NK cells were also stained.